Cargando…

Intratumoral Switch of Molecular Phenotype and Overall Survival in Muscle Invasive Bladder Cancer

SIMPLE SUMMARY: The Cancer Genome Atlas (TCGA) and more recent genome profiling recently revealed major intrinsic molecular subtypes in urothelial carcinoma (UC). Here we propose a fast and standardized immunophenotypical classification score (Piescore) that may discriminate between luminal, basal,...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Carlo, Camilla, Valeri, Marina, Rudini, Noemi, Zucali, Paolo Andrea, Cieri, Miriam, Elefante, Grazia Maria, D’antonio, Federica, Hurle, Rodolfo, Giordano, Laura, Bressan, Alessandra, Lazzeri, Massimo, Perrino, Matteo, Guazzoni, Giorgio, Terracciano, Luigi Maria, Colombo, Piergiuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265094/ https://www.ncbi.nlm.nih.gov/pubmed/35805028 http://dx.doi.org/10.3390/cancers14133256

Ejemplares similares

Case Report: Unclassified Renal Cell Carcinoma With Medullary Phenotype and SMARCB1/INI1 Deficiency, Broadening the Spectrum of Medullary Carcinoma
por: Valeri, Marina, et al.
Publicado: (2022)

Case report: Primary Ewing sarcoma of the ureter, an exceptional finding of unique manifestation of disease
por: Valeri, Marina, et al.
Publicado: (2023)

Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients
por: Valeri, Marina, et al.
Publicado: (2023)

Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under “Active Surveillance” for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study
por: Fasulo, Vittorio, et al.
Publicado: (2022)

Long-term Follow-up After En Bloc Transurethral Resection of Non–muscle-invasive Bladder Cancer: Results from a Single-center Experience
por: Paciotti, Marco, et al.
Publicado: (2021)

Intravesical gemcitabine as bladder‐preserving treatment for BCG unresponsive non‐muscle‐invasive bladder cancer. Results from a single‐arm, open‐label study
por: Hurle, Rodolfo, et al.
Publicado: (2020)

Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial
por: Contieri, Roberto, et al.
Publicado: (2022)

How I faced my prostate cancer: a molecular biologist’s perspective
por: Zuradelli, Monica, et al.
Publicado: (2021)

Usefulness of pT1 substaging in papillary urothelial bladder carcinoma
por: Patriarca, Carlo, et al.
Publicado: (2016)

Non-muscle invasive bladder cancer biomarkers beyond morphology
por: De Carlo, Camilla, et al.
Publicado: (2022)

Safety and Feasibility of Salvage Endoscopic Combined Intrarenal Surgery in Embolized Kidney
por: Benincasa, Alfonso, et al.
Publicado: (2016)

Use of 29-MHz Micro-ultrasound for Local Staging of Prostate Cancer in Patients Scheduled for Radical Prostatectomy: A Feasibility Study
por: Regis, Federica, et al.
Publicado: (2020)

Editorial: New frontiers in “bladder sparing” treatments for high risk NMIBC
por: Hurle, Rodolfo, et al.
Publicado: (2023)

Targeted 11C–choline PET-CT/TRUS software fusion-guided prostate biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy
por: Lazzeri, Massimo, et al.
Publicado: (2017)

How Are We Facing It? Dispatches From Pathology Residents in a COVID-19 Lombardy Hospital
por: Cieri, Miriam, et al.
Publicado: (2020)

Evaluation of Semen Self-Sampling Yield Predictors and CTC Isolation by Multi-Color Flow Cytometry for Liquid Biopsy of Localized Prostate Cancer
por: Saitta, Cesare, et al.
Publicado: (2023)

Mast Cells as a Potential Prognostic Marker in Prostate Cancer
por: Taverna, Gianluigi, et al.
Publicado: (2013)

Clinical and pathological predictors of persistent T1 HG at second resection
por: Gobbo, Andrea, et al.
Publicado: (2023)

External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era
por: Frego, Nicola, et al.
Publicado: (2022)

Post-Biopsy Cell-Free DNA From Blood: An Open Window on Primary Prostate Cancer Genetics and Biology
por: Corbetta, Marinella, et al.
Publicado: (2021)

Assessing the Role of High-resolution Microultrasound Among Naïve Patients with Negative Multiparametric Magnetic Resonance Imaging and a Persistently High Suspicion of Prostate Cancer
por: Avolio, Pier Paolo, et al.
Publicado: (2022)

Exceptional Symbiosis Between Tumors: A Case of Gastric Signet Ring Cell Metastasis in Chromophobe Carcinoma of the Kidney
por: Cieri, Miriam, et al.
Publicado: (2021)

Current Perspectives on Immunotherapy in the Peri-Operative Setting of Muscle-Infiltrating Bladder Cancer
por: Zucali, Paolo Andrea, et al.
Publicado: (2020)

Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
por: Molon, Barbara, et al.
Publicado: (2011)

Energy metabolism in glioblastoma stem cells: PPARα a metabolic adaptor to intratumoral microenvironment
por: Fidoamore, Alessia, et al.
Publicado: (2017)

Impact of Real-Time Elastography versus Systematic Prostate Biopsy Method on Cancer Detection Rate in Men with a Serum Prostate-Specific Antigen between 2.5 and 10 ng/mL
por: Taverna, Gianluigi, et al.
Publicado: (2013)

Delayed Diagnosis of a Testicular Mass During COVID-19 Pandemic in Lombardy: A Case Report
por: Cieri, Miriam, et al.
Publicado: (2021)

Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer
por: Lazzeri, Massimo, et al.
Publicado: (2022)

Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer
por: Masetti, Michela, et al.
Publicado: (2021)

Systemic treatments for thymic tumors: a narrative review
por: Zucali, Paolo Andrea, et al.
Publicado: (2021)

Intratumoral CD3+ T-Lymphocytes Immunoexpression and Its Association with c-Kit, Angiogenesis, and Overall Survival in Malignant Canine Mammary Tumors
por: Carvalho, Maria Isabel, et al.
Publicado: (2015)

Zonal Intratumoral Delivery of Nanoparticles Guided by Surface Functionalization
por: Terracciano, Rossana, et al.
Publicado: (2022)

Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A Review
por: Capelli, Laura, et al.
Publicado: (2016)

Effects of Surface Protein Adsorption on the Distribution and Retention of Intratumorally Administered Gold Nanoparticles
por: Terracciano, Rossana, et al.
Publicado: (2021)

Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy
por: Gao, Feng, et al.
Publicado: (2015)

Bladder metastases of appendiceal mucinous adenocarcinoma: a case presentation
por: Taverna, Gianluigi, et al.
Publicado: (2010)

Digital Pathology During the COVID-19 Outbreak in Italy: Survey Study
por: Giaretto, Simone, et al.
Publicado: (2021)

Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma
por: Coto-Llerena, Mairene, et al.
Publicado: (2022)

Prediction of overall survival in patients with pancreatic ductal adenocarcinoma: histogram analysis of ADC value and correlation with pathological intratumoral necrosis
por: Noda, Yoshifumi, et al.
Publicado: (2022)

Leukocytes infiltration correlates intratumoral microvessel density and influence overall and late-phase disease-free survival in hepatocellular carcinoma
por: Yang, Yuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qfbr34cl18jn6fm6t7dsa48epr